Should a patient be given extended endocrine therapy if she was on a lower dose than recommended for part of her treatment?

Two questions here:

1. Does she need extended endocrine therapy? Several extended endocrine therapy trials using AI or a switch strategy showed lack of a significant benefit with improving disease free survival (summarized here: https://www.healio.com/hematology-oncology/breast-cancer/news/print/hemo...